RASOLVE
LIVE

Serial Number

98586546

Owner

Revolution Medicines, Inc.

Attorney

Melissa A. Nowak

Filing Date

Jun 5, 2024

Add to watchlist:

No watchlists yet
View on USPTO

RASOLVE Trademark

Serial Number: 98586546

RASOLVE is a trademark filed by Revolution Medicines, Inc. on June 5, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Revolution Medicines, Inc. (52 trademarks)

700 Saginaw Drive
Redwood City, CA 94063

Entity Type: 03

Trademark Details

Filing Date

June 5, 2024

Registration Date

Not Registered

Published for Opposition

January 14, 2025

Goods & Services

Providing medical information about oncological and immune system related diseases and disorders in the field of pharmaceuticals and clinical trials for a clinical trial retention program

Pharmaceutical preparations for the treatment of oncological and immune system related diseases and disorders

Providing medical research information about oncological and immune system related diseases and disorders in the field of pharmaceuticals and clinical trials for a clinical trial retention program

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 27, 2026 EXRA
SOU EXTENSION 2 GRANTED
Jan 26, 2026 EX2G
SOU EXTENSION 2 FILED
Jan 26, 2026 EXT2
SOU TEAS EXTENSION RECEIVED
Jan 26, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 11, 2025 EXRA
SOU EXTENSION 1 GRANTED
Sep 11, 2025 EX1G
SOU EXTENSION 1 FILED
Sep 10, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Sep 10, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 11, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 14, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jan 14, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 8, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 19, 2024 CNSA
ASSIGNED TO EXAMINER
Dec 18, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 17, 2024 NWOS
NEW APPLICATION ENTERED
Jun 5, 2024 NWAP